Cashu | News | CAPR

HomeWatchlistNewsSignalsPicks

DJI

-0.41%

SPX

-0.09%

IXIC

+0.14%

FTSE

-0.46%

N225

+0.39%

AXJO

+0.04%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Capricor Therapeutics News

FDA Skips Advisory Committee For Capricor's Duchenne Cell Therapy

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com

about 24 hours ago

Why Is Capricor Therapeutics Stock Trading Lower On Monday?

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com

Capricor Reports 4-Year Data For Deramiocel, Shows Sustained Benefit In Duchenne Patients

12 Health Care Stocks Moving In Friday's Intraday Session

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Feature Image for interests on Big Losers, Consumer Cyclical, Healthcare, Markets from benzinga.com

Decoding Capricor Therapeutics's Options Activity: What's the Big Picture?

Behind the Scenes of Capricor Therapeutics's Latest Options Trends

New FDA Leadership Could Raise The Bar For Drug Approvals

Feature Image for interests on Benzinga, Biotech, Contributors, Equities from benzinga.com

about 2 months ago

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation

Feature Image for interests on Analyst Color, Analyst Ratings, Bbc, Benzinga from benzinga.com

about 2 months ago

finance.yahoo.com

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Feature Image for interests on Capricor, Capricor Therapeutics, Healthcare, Product Candidates from finance.yahoo.com

Latest Cashu News

Capricor Therapeutics Progresses in Muscular Dystrophy Research Despite Market Challenges

Capricor Therapeutics Advances Deramiocel for Duchenne Muscular Dystrophy Treatment

Capricor Therapeutics (CAPR) Faces Bearish Sentiment from Institutions Amid Market Uncertainty

Stocks

Health Care

capr

Capricor Therapeutics

CAPR

+0.91 (+9.84%)

10.16

USD

At close at Jun 25, 18:40 UTC